- Global Pharma News & Resources

Antipsychotic Drugs Market Perspective with Analysis of Key Players & Revenue Forecast To 2028

Drugs used in treatment of psychosis and related illnesses are referred to as antipsychotic drugs. Antipsychotic drugs are also referred to as neuroleptics. Common type of illness and disorders wherein these type of drugs are used for treatment include, schizophrenia, delusions, bipolar disorders, among others.

Increasing incidence of psychotic disorders and presence of large patient pool in developed and in some developing economies are major factors driving adoption of antipsychotic drugs and in turn fueling growth of the global antipsychotic drugs market. Additionally, increasing availability of advanced antipsychotic drugs that are used for specialized treatment of certain psychotic disorders is another factor anticipated to boost growth of the global market over the forecast period. However, high associated costs and side effects caused due to use of antipsychotic drugs are major factors hampering growth of the global market.

The global antipsychotic drugs market report has been segmented on the basis of drug generation type, application, and region. On the basis of region, the global antipsychotic drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global antipsychotic drugs market segmentation:

By drug generation type:

  • First Generation
    • Thorazine (Chlorpromazine HCl)
    • Serentil (Mesoridazine Besylate)
    • Mellaril (Thioridazine HCl)
    • Haldol (Haloperidol)
    • Loxitane (Loxapine Succinate)
    • Trilafon (Perphenazine)
    • Navane (Thiothixene)
    • Sordinol (Clopenthixol)
  • Second Generation
    • Zyprexa (Olanzapine)
    • Geodon (Ziprasidone)
    • Seroquel (Quetiapine)
    • Risperdal (Risperidone)
    • Clozaril (Clozapine)
    • Invega (Paliperidone)
    • Asendin (Amoxapine)
    • Latuda (Lurasidone)
  • Third Generation
    • Abilify (Aripiprazole)

By application:

  • Schizophrenia
  • Bipolar Disorder
  • Dementia
  • Unipolar Depression
  • Other

Get Free Sample Copy Of This Research @

The market in North America accounted for highest share in terms of revenue in the global market, and is projected to maintain its dominance over the forecast period. This can be attributed to presence of proper medical infrastructure, high awareness about psychotic disorders and use of antipsychotic drugs in countries in the region. Moreover, presence of large patient pool, especially in the US is another major factor expected to propel growth of the North America antipsychotic drugs market over the forecast period.

Prominent players in the global antipsychotic drugs market include Johnson & Johnson, Pfizer Inc., Eli Lilly and Co., Bristol-Myers Squibb, AstraZeneca Plc., Allergan, Inc., and GlaxoSmithKline Plc.

Editor Details

Last Updated: 14-Feb-2019